Single-Cell Heterogeneity Analysis and CRISPR Screen Identify Key Β-Cell-specific Disease Genes.

Zhou Fang,Chen Weng,Haiyan Li,Ran Tao,Weihua Mai,Xiaoxiao Liu,Leina Lu,Sisi Lai,Qing Duan,Carlos Alvarez,Peter Arvan,Anthony Wynshaw-Boris,Yun Li,Yanxin Pei,Fulai Jin,Yan Li
DOI: https://doi.org/10.1016/j.celrep.2019.02.043
IF: 8.8
2019-01-01
Cell Reports
Abstract:Identification of human disease signature genes typically requires samples from many donors to achieve statistical significance. Here, we show that single-cell heterogeneity analysis may overcome this hurdle by significantly improving the test sensitivity. We analyzed the transcriptome of 39,905 single islets cells from 9 donors and observed distinct β cell heterogeneity trajectories associated with obesity or type 2 diabetes (T2D). We therefore developed RePACT, a sensitive single-cell analysis algorithm to identify both common and specific signature genes for obesity and T2D. We mapped both β-cell-specific genes and disease signature genes to the insulin regulatory network identified from a genome-wide CRISPR screen. Our integrative analysis discovered the previously unrecognized roles of the cohesin loading complex and the NuA4/Tip60 histone acetyltransferase complex in regulating insulin transcription and release. Our study demonstrated the power of combining single-cell heterogeneity analysis and functional genomics to dissect the etiology of complex diseases.
What problem does this paper attempt to address?